Induction of 2G12 neutralizing antibody by plant-derived HIVgp145
Induction of 2G12 neutralizing antibody by plant-derived HIVgp145
批准号:
7336641
负责人:
Yvonne J Rosenberg
金额:
$22.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2009-01-31
关键词:
AntibodiesAntibody FormationAwardBasic ScienceBindingBiochemicalBiologyCaviaCell LineComplexCultured CellsDevelopmentEndoplasmic ReticulumEpitopesExhibitsExposure toFaceFundingGaggingGlycoproteinsGoalsGolgi ApparatusGrantHIVHIV Envelope Protein gp120HIV InfectionsHIV vaccineHumanImmune responseIndividualInfectionMacacaMannoseMannosidaseModelingMolecular BiologyOralPathway interactionsPhasePlant ProteinsPlantibodiesPlantsPolysaccharidesProductionPropertyProteinsRecombinantsSIVSmall Business Funding MechanismsSmall Business Innovation Research GrantStandards of Weights and MeasuresSystemTestingTobaccoTransgenic OrganismsVaccinatedVaccinationVaccinesVaginaVariantconceptcostdesignenv Gene Productsimmunogenicimmunogenicityneutralizing antibodyneutralizing monoclonal antibodiesprogramsresponsescale upsimian human immunodeficiency virustraffickingtransmission processvaccine development
中文摘要
描述(由申请人提供):艾滋病毒感染和疫苗在诱导中和初级分离株的抗体方面一直令人失望地糟糕,因此鉴定一个高免疫原性中和表位/S是当务之急。最近已经产生了几种广泛交叉反应的人类中和单抗,它们结合在一起,被证明可以被动地保护猕猴免受SIV的阴道传播。其中一个单抗2G12是独一无二的,因为它识别一个表位,该表位由gp120外表面上多达三个寡注链(残基332、392和295)组成的簇。大多数感染者不会产生2G1样的中和抗体,可能是因为高甘露糖多糖在糖蛋白通过分泌途径运输时被修剪掉了。为了测试这一概念,ProcCell使用植物表达系统生产了一种高甘露糖形式的HIV gp145,方法是使用KDEL标签将HIV gp145的合成特异性地靶向内质网,该标签阻止进入高尔基体并接触甘露糖苷酶。这些高甘露糖HIV env分子与2G12的反应性强于CHO来源的env,这表明高甘露糖和分泌型HIV env之间存在重要的结构差异。目前提案的目的是生产分泌型gp145(包括复杂和高甘露糖的混合物),并比较高甘露糖型HIV gp145 env与植物和细胞培养来源的分泌型gp120/160分子的生化、功能和免疫学特性。植物衍生蛋白将在转基因烟草植物和细胞系中产生,纯化后用于免疫豚鼠,以评估两种糖类的免疫原性差异。
这种方法代表了一个重要的新概念,通过诱导强中和类2G12抗体和其他针对未知高甘露糖表位的潜在中和抗体来优化疫苗效率。它还强调了植物表达系统在生产不同糖型蛋白质方面的有用性。
英文摘要
DESCRIPTION (provided by applicant): HIV infections and vaccines have historically been disappointingly poor at eliciting antibodies that neutralize primary isolates, thus the identification of a highly immunogenic neutralizing epitope/s is of the highest priority. Recently several broadly crossreactive human neutralizing monoclonal antibodies have been generated, which in combination, have been shown to passively protect macaques against vaginal SIV transmission. One of these MAbs, 2G12 is unique in that it recognizes an epitope that is comprised of a cluster of up to three oligomannose chains (residues 332, 392 and 295) on the outer face of gp120. Most infected individuals do not make 2G1like neutralizing antibodies, perhaps because the high mannose glycans are trimmed as the glycoproteins traffic through the secretory pathway. To test this concept, ProcCell has used the plant expression system to produce a high-mannose form of HIV gp145 by specifically targeting synthesis of HIV gp145 to the endoplasmic reticulum using a KDEL tag which blocks exit into the Golgi and exposure to mannosidases. These high-mannose HIV Env molecules exhibited stronger reactivity with 2G12 than CHO-derived Env, suggesting important structural differences between high mannose and secreted forms of the HIV Env. The aim of the current proposal is to produce the secreted form of the gp145 (comprising a mix of complex and high mannose glycans) and to compare the biochemical, functional and immunological properties of the high-mannose form of HIV gp145 Env with both plant and cell culture-derived secreted gp120/160 molecule. Plant- derived proteins will be produced in transgenic tobacco plants and cell lines, purified and used to immunize guinea pigs to assess differences in immunogenicity of the two glycoforms.
This approach represents an important new concept in optimizing vaccine efficiency by the induction of strong neutralizing 2G12-like antibodies and other potentially neutralizaing antibodies specific for yet unknown high mannose epitopes. It also highlights the usefulness of the plant expression systems in producing different glycoforms of proteins.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0120451
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Rosenberg Y, Sack M, Montefiori D, Labranche C, Lewis M, Urban L, Mao L, Fischer R, Jiang X]
通讯作者:
Jiang X
Zwitterionic oxime (RS194B) to reverse advanced symptoms and lethality of organophosphate pesticide exposure
-
批准号:9621314
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2018
-
负责人:Yvonne J Rosenberg
-
依托单位:
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing
-
批准号:10079784
-
项目类别:
-
资助金额:$70.58万
-
财政年份:2018
-
负责人:Yvonne J Rosenberg
-
依托单位:
Development of a handheld PEST-pen device for the rapid detection of organophosphate insecticides on food and clothing
-
批准号:10259769
-
项目类别:
-
资助金额:$51.51万
-
财政年份:2018
-
负责人:Yvonne J Rosenberg
-
依托单位:
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques
-
批准号:9312216
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2016
-
负责人:Yvonne J Rosenberg
-
依托单位:
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm
-
批准号:8738719
-
项目类别:
-
资助金额:$85.89万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag
-
批准号:7612606
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev
-
批准号:8210828
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm
-
批准号:8523566
-
项目类别:
-
资助金额:$75.34万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag
-
批准号:7888255
-
项目类别:
-
资助金额:$54.57万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm
-
批准号:9121644
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev
-
批准号:7685238
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Aerosol Delivery of a Recombinant Butyrylcholinesterase "BioShield" to Protect Ag
-
批准号:8139033
-
项目类别:
-
资助金额:$61.81万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
Passive immunotherapy using plant-derived broadly HIV-1 neutralizing MAbs to prev
-
批准号:8071732
-
项目类别:
-
资助金额:$72.6万
-
财政年份:2009
-
负责人:Yvonne J Rosenberg
-
依托单位:
A Plant-Derived Recombinant Bioscavenger to Prevent Insecticide Neurotoxicity
-
批准号:7271629
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2007
-
负责人:Yvonne J Rosenberg
-
依托单位:
Immunogenicity of plant-expressed p55 Gag and gp120
-
批准号:6696065
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2003
-
负责人:Yvonne J Rosenberg
-
依托单位:
海外基金